Help
RSS
API
Feed
Maltego
Contact
Domain > www.biomolecularproducts.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-10-23
65.182.101.130
(
ClassC
)
Port 80
HTTP/1.1 200 OKDate: Wed, 23 Oct 2024 02:49:17 GMTServer: Apache/2.0.52X-Powered-By: PHP/5.2.9Connection: closeTransfer-Encoding: chunkedContent-Type: text/html; charsetUTF-8 !DOCTYPE HTML PUBLIC -//W3C//DTD HTML 4.01 Transitional//EN http://www.w3.org/TR/html4/loose.dtd>HTML>head>META HTTP-EQUIVContent-Type CONTENTtext/html; charsetISO-8859-1>meta namekeywords contentlym-x-sorb, lym x sorb, drug delivery, LXS, L-X-S, lipid matrix, lipid glove, lipid complex, increased bioavailability, GRAS lipids, non-liposomal, inverse, hexagonal, lamellar, non-lamellar, nutritional supplement, cationic transfection, BioMolecular Products, David Yesair, fenretinide powder, fenretinide oral powder, oral fenretinide, fenretinide lipid matrix, 4-HPR/LXS, fenretinide LXS, non-liposomal lipid-based drug delivery system, Modifications of solid 3-sn-phosphoglycerides, phospholipase A 2 hydrolysis, lysophosphatidylcholine, monoglyceride, and fatty acid malabsorption, vitamin A, low surface tension, Organized Lipid Matrix, Fatty Acids and Choline in Cystic Fibrosis>meta namegoogle-site-verification contentmMUD4TE8evSFnKF_t24XoY3jbl-HBCY4y2UJCYptCSM /> !--Google Search Consule-->meta nameviewport contentwidthdevice-width, initial-scale1, maximum-scale1, user-scalableno>title>Biomolecular Products, Inc.: Home/title>link relstylesheet typetext/css hrefbmp.css>!--if lte IE 7>link relstylesheet hrefie7.css typetext/css />!endif--> !--if gte IE 8>link relstylesheet hrefie8.css typetext/css />!endif--> SCRIPT LANGUAGEJavaScript>!-- This script and many more are available free online at -->!-- The JavaScript Source!! http://javascript.internet.com -->!-- Beginfunction right(e) {var msg Sorry, you dont have permission to right-click.;if (navigator.appName Netscape && e.which 3) {alert(msg);return false;}if (navigator.appName Microsoft Internet Explorer && event.button2) {alert(msg);return false;}else return true;}function trap() { if(document.images) { for(i0;idocument.images.length;i++) { document.imagesi.onmousedown right; document.imagesi.onmouseup right; } } }// End -->/SCRIPT>!-- Google tag (gtag.js) -->script async srchttps://www.googletagmanager.com/gtag/js?idG-K18G67H4GP>/script>script> window.dataLayer window.dataLayer || ; function gtag(){dataLayer.push(arguments);} gtag(js, new Date()); gtag(config, G-K18G67H4GP);/script>style> @media (max-width: 767px) { body { width: 99%;} h2 {margin-top: 0;} ul.menu { padding: 10px; margin: 0; clear: both; }ul.menu li { display: inline; text-align: center; padding: 2px; margin: 5px; line-height: 2; font-size: 130%;}ul.menu a { padding: 2px; border: 2px solid #ccc; /*#ceb719;*/ border-radius: 0px 10px 0px 10px;} ul.menu li ul { width: 100%; margin: 0; } }/style>/HEAD>!-- Script Size: 0.81 KB -->/head>BODY onLoadtrap()>!--if lte IE 7>p stylefont-size: 80%;>I>This site has been optimized for modern browsers. Please update your browser to the newest version of A HREFhttp://windows.microsoft.com/en-US/internet-explorer/products/ie/home targetnew>Internet Explorer/A> or switch to another free browser (such as A HREFhttp://www.google.com/chrome/intl/en/landing_chrome.html?hlen targetnew>Chrome/A>) to view this website./I>!endif--> div idbox>div idheaderbox>div idheader>A HREF/>img srcimg/logo.jpg classlogo>/A>BR>h1>BioMolecular Products, !--/h1> h1 classsmall>-->Inc./h1>h2>BR>Lym-X-Sorb®: BR>A Revolution in Drug Delivery/h2>ul classmenu>li>A HREFindex.php classcurrent>Home/A>/li>!--li>A HREFnews.php >News/A>/li>-->li>A HREFlym-x-sorb.php>Lym-X-Sorb® (+)/A>ul >li>A HREFdrug_delivery.php >Drug Delivery/A>/li>li>A HREFnutritional.php >Nutritional/A>/li>li>A HREFdermatological.php >Dermatological/A>/li> /ul>/li>li>A HREFstudies.php >Studies (+)/A> ul > li>A HREFnutritional_studies.php >Nutritional/A>/li> li>A HREFpharmaceutical_studies.php >Pharmaceutical/A>/li> /ul>/li>li>A HREFpublications.php >Publications/A>/li>li>A HREFabout.php>About/A>/li>li>A HREFcontact.php>Contact/A>/li>/ul>/div>div idcontent>div idsidebar>h4 stylemargin-top: 15px;>Vytala Inc Debuts With Initial Close of Pre-Seed Financing to End Nutrient Deficiencies in Patients With Digestive Disorders/h4>p>BioMolecular Products is very pleased to announce that Lym-X-Sorb® technology has been licensed to Vytala. Please see Vytala’s press release A HREFhttps://www.businesswire.com/news/home/20240917926343/en/Vytala-Inc-Debuts-With-Initial-Close-of-Pre-Seed-Financing-to-End-Nutrient-Deficiencies-in-Patients-With-Digestive-Disorders targetnew>here/A>. For more information, please visit A HREFhttp://www.vytalahealth.com/ targetnew>Vytala’s website/A> or contact via A HREFmailto:info@VytalaHealth.com>email/A> or A HREFhttps://www.linkedin.com/company/vytala/ targetnew>LinkedIn/A>. BR>BR>h4>A HREFhttps://www.prnewswire.com/news-releases/vytala-launches-seracal-improving-nutrient-absorption-and-providing-essential-fatty-acids-to-patients-with-malabsorption-302262794.html targetnew>Vytala Launches Seracal™:/A> Improving Nutrient Absorption and Providing Essential Fatty Acids to Patients with Malabsorption/h4>BR>h4>Lym-X-Sorb®: A HREFdocs/Fact Sheet page 2020.pdf targetnew>Fact Sheet/A>/h4>!--h4>News:/h4>p>BioMolecular Products is pleased to announce that Lym-X-Sorb® technology has been licensed to Envara Health. For more information, please contact A HREFhttps://envarahealth.com targetnew>Envara Health, Inc/A>.h5>Envara Health Launches Encala® to Enhance Fat Absorption and Provide Healthy Calories for Patients with Cystic Fibrosis/h5>p>WAYNE, Pa., Oct. 20, 2020 /PRNewswire/ -- Envara Health, a venture backed company focused on advanced nutrition, has launched a new, clinically proven medical food Encala®, formulated to address fat malabsorption in patients with cystic fibrosis (CF) and other exocrine pancreatic diseases. The product is unique in its ability to provide both easily absorbable fat calories and improve the absorption of fat and nutrients in accompanying meals and beverages.p>I>Please A HREFhttps://www.prnewswire.com/news-releases/envara-health-launches-encala-to-enhance-fat-absorption-and-provide-healthy-calories-for-patients-with-cystic-fibrosis-301155475.html targetnew>click here/A> for more information./I>h3>News:/h3>p>B>Study shows positive results in children with cystic fibrosis and pancreatic insufficiency who are administered Lym-X-Sorb:/B> Two recently published papers showed positive nutritional results compared to placebo when Lym-X-Sorb is administered to children with cystic fibrosis (CF) and pancreatic insufficiency: A HREFhttp://www.pubpdf.com/pub/27050056/Effect-of-Oral-Lipid-Matrix-Supplement-on-Fat-Absorption-in-Cystic-Fibrosis-A-Randomized-Placebo-Con targetnew>EFFECT OF ORAL LIPID MATRIX SUPPLEMENT ON FAT ABSORPTION IN CYSTIC FIBROSIS: A RANDOMIZED PLACEBO-CONTROLLED TRIAL/A> and a hrefhttps://www.ncbi.nlm.nih.gov/pubmed/26465792 targetnew>Choline Supplementation With a Structured Lipid in Children With Cystic Fibrosis: A Randomized Placebo-Controlled Trial/A>. Please A HREFstudies.php>click here/A> for more information.h4>A HREFnews.php>News Archives/A>/h4>-->/div>h3>About BioMolecular Products, Inc.:/h3>!--p>span classsc>BioMolecular Products, Inc./span> (BMP) is a Massachusetts corporation, founded in 1984 by A HREFabout.php>Dr. David Yesair/A>. BMP currently owns a portfolio of five U.S. patents and 11 foreign patents surrounding the lipid-based technology Lym-X-Sorb®, winner of the 2004 Eurand Award. Lym-X-Sorb® is a novel lipid matrix that can improve the absorption of nutritional and pharmaceutical substances. The technology has completed a human clinical study at the Hôpital Sainte Justine Pediatric Research Center and is currently in clinical studies at the Childrens Hospital of Philadelphia. Studies are also underway using powderized Lym-X-Sorb® as the drug delivery vehicle for fenretinide as a treatment for various cancers.!-->p>span classsc>BioMolecular Products, Inc./span>, founded in 1984, owns the lipid-based technology Lym-X-Sorb®, winner of the 2004 Eurand Award. Lym-X-Sorb® (B>I>Lym/I>/B>phatic B>I>X/I>/B>enobiotic AbB>I>Sorb/I>/B>ability)!--, newly marketed by Envara Health under the name Encala™, is a unique patented drug and nutritional delivery system with controlled release.p>-->. When manufactured and formulated with a drug or nutritive agent, the Lym-X-Sorb® monomer shields the drug or nutritive from the hostile environs of the stomach and the upper intestine by enveloping it in the void created among the acyl-constituents of the lipid anchors. Lym-X-Sorb® is a novel lipid matrix that can improve the absorption of nutritional, dermatologic, and pharmaceutical substances. Numerous successful studies have been done with a variety of difficult to absorb drugs as well as using Lym-X-Sorb® as a nutritional supplement for children with cystic fibrosis. !--h3>Lym-X-Sorb®:BR>a Revolution in Oral Drug Delivery/h3>p classleft_caption>img srcimg/LXS_f.jpg altLym-X-Sorb monomer complexed (in a conceptual model) with a molar equivalent of fenretinide, in yellow.>Lym-X-Sorb® monomer complexed (in a conceptual model) with a molar equivalent of fenretinide, in yellow.!-->h4>What can Lym-X-Sorb® (LXS™) do?/h4>ul>li>Improved clinical efficacy with fewer side effects./li>li>Increased bioavailability & excellent drug compatibility./li>li>Protects oxygen, heat and light labile drugs./li>li>Protects drugs in acidic and basic environments./li>li>Protects the stomach and intestine from irritant drugs./li>li>Nutritional, drug delivery, dermatological applications./li>li>Various end products with multiple routes of delivery from gel to powderized./li>li>Proven in multiple and varied studies./li>li>Multiple applications in numerous markets with potential high return./li>li>Clear and defined advantages over competing products./li>li>Rapid growth potential./li>li>Well-developed and researched technology./li>/ul>h4>Rearrangement of LXS™ Monomeric StructureBR>(interpretation of X-ray data):/h4>p>IMG SRCimg/lxs_structures.jpg altRearrangement of LXS™ Monomeric Structure (interpretation of X-ray data)>!--h4>Benefits of Using Lym-X-Sorb®:/h4>table stylemargin-top: -20px; width: 1000px;>tr>td valigntop>ul stylewidth: 430px; margin-right: -20px;>li>Recover your clinical and R&D chemical dropouts./li>li>Protect your technology with multiple patents./li>li>Reduce regulatory hurdles with GRAS listed components./li>li>Multiple routes of drug delivery./li>li>Fewer side effects./li>li>Improved clinical efficacy./li>li>Proven, patented and tested./li>/ul>/td>td valigntop>ul stylewidth: 430px; >li>Compatible with a large number of drugs./li>li>Protects oxygen, heat and light labile drugs./li>li>Protects drugs in acidic and basic environments./li>li>Protects the stomach and intestine from irritant drugs./li>li>Minimizes the taste of the drug./li>li>Minimizes the effect of food./li>li>Enhanced compliance./li>/ul>/td>/tr>/table>!-->BR styleclear: both;>/div>div idfooter>h4>Menu:/h4> table>tr>td stylepadding-left: 0px; valigntop>h5>A HREFindex.php classcurrent>Home/A>/h5>/td>!--td valigntop>h5>A HREFnews.php >News/A>/h5>/td>-->td valigntop>h5>A HREFlym-x-sorb.php>Lym-X-Sorb®/A>/h5>BR>A HREFdrug_delivery.php >Drug Delivery:/A> BR>A HREFFenretinide_Cyclosporine.php >I>Fenretinide & Cyclosporine/I>/A>BR>BR>A HREFnutritional.php >Nutritional:/A> BR>A HREFmalnutrition_sports.php >I>Malnutrition & Sports Applications/I>/A>BR>BR>A HREFdermatological.php >Dermatological/A>/td>td valigntop>h5>A HREFstudies.php >Studies/A>/h5>BR>A HREFnutritional_studies.php >Nutritional/A>BR> A HREFpharmaceutical_studies.php >Pharmaceutical/A>BR>/td>td valigntop>h5>A HREFpublications.php >Publications/A>/h5>/td>td valigntop>h5>A HREFabout.php>About/A>/h5>/td>td valigntop>h5>A HREFcontact.php>Contact/A>/h5>/td>/tr>/table>BR>BR>h4>Contact:/h4>p>B>Robert Gould,/B> I>President/i>, span classsc>BioMolecular Products, Inc./span>BR>B>Address:/B> 52 Bradford Avenue, Bradford, Massachusetts (MA) 01835, USABR>B>Phone:/B> (978) 478-6470; B>Email:/B> A HREFmailto:biomolecular@comcast.net>biomolecular@comcast.net/A>BR>BR>h4>Find Us on Facebook:/h4>p>iframe srchttp://www.facebook.com/plugins/likebox.php?id259189414122405&width475&connections0&streamfalse&headertrue& scrollingno frameborder0 styleborder:none; overflow:hidden; height: 60px; width:475px; background: transparent; allowTransparencytrue>/iframe>br>br>h4>i>Copyright © 2008-2024 Biomolecular Products Inc. All rights reserved./I>/h4>/div>BR>BR styleclear: both; margin: 0px; padding: 0px; height: 0px;>CENTER>A HREFhttp://www.linebylinewebdesign.com targetnew>B>I>Line by Line web design/I>/B>/A>/CENTER>/BODY>/HTML>
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]